TP53 and cancer: The pervasive retention of mutp53 in cancer suggests a selective advantage; indeed, missense p53 mutants have been reported to foster cancer cell proliferation, invasion, metastasis, and chemoresistance (Pilley et al., 2021; Dolma and Muller, 2022).